Business Intelligence & Development
STCC's industry partnership gateway for cancer-related clinical and research collaborations.
STCC's Business Intelligence & Development (BID) platform serves as the gateway to Singapore's cancer research ecosystem, connecting pharmaceutical companies, biotechnology firms, MedTech innovators, diagnostics developers and healthcare organisations with leading cancer clinicians, researchers and institutions across Singapore.
Through strategic partnership development, market intelligence and ecosystem engagement, BID helps organisations identify collaboration opportunities, evaluate clinical trial feasibility, access specialised research capabilities and develop translational research programmes. By connecting academia, healthcare and industry, the platform accelerates the development of new diagnostics, therapies and healthcare technologies that improve outcomes for cancer patients.
Why Partner Through BID?
Access Singapore's Cancer Research Ecosystem
Connect with a coordinated network of cancer centres, clinician-scientists, researchers and healthcare institutions across Singapore.
Accelerate Clinical Trial Development
Explore opportunities for industry-sponsored trials, investigator-initiated trials, early-phase studies and translational research programmes.
Strategic Research Collaborations
Match scientific priorities with leading disease experts, tumour groups and multidisciplinary research teams.
Leverage Global and Regional Networks
Build partnerships that connect local expertise with international oncology research and pharmaceutical innovation.
Connecting Global Innovation with Singapore's Cancer Research Ecosystem
BID has established relationships across the global oncology ecosystem, engaging pharmaceutical companies, biotechnology firms, diagnostics developers and healthcare innovators spanning North America, Europe and Asia.
These engagements support the development of:
Clinical trials and feasibility studies
Translational research collaborations
Biomarker and genomics programmes
Novel diagnostics and medical technologies
Academic-industry partnerships
.jpeg)
Why Singapore?
Singapore offers a uniquely integrated cancer research environment, bringing together leading healthcare institutions, clinician-scientists, translational research capabilities and diverse patient populations within a highly collaborative ecosystem.
Through BID, organisations gain a single point of access to this ecosystem, simplifying partnership development and accelerating research execution.
Explore Partnership Opportunities
Connect with Singapore's leading cancer researchers, clinicians and institutions to explore clinical trials, translational research and strategic partnership opportunities.